STAT3 and neoplasm: Additionally, elevated levels of aldehyde dehydrogenase (ALDH) in endometrial cancer can promote CSC traits through IL-6/JAK1/STAT3-mediate pathways, thereby blocking these pathways declined tumor growth and progression [146].